(Q36817092)

16 August 2017

Mutant MHC class II epitopes drive therapeutic immune responses to cancer (English)

1 reference

Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer

16 August 2017

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/NATURE14567

author

Mathias Vormehr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sebastian Boegel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Uğur Şahin

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

14

Özlem Türeci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1

Sebastian Kreiter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

9

Fulvia Vascotto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

4

Mustafa Diken

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

13

Christoph Huber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

8

Barbara Schrörs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

5

Martin Löwer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

6

Jan Diekmann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

11

Arbel D Tadmor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

3

Niels van de Roemer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

John C Castle

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Stephen P Schoenberger

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

English

0 references

publication date

22 April 2015

1 reference

16 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

520

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

7549

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

692-696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines

10 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

PD-1 blockade induces responses by inhibiting adaptive immune resistance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Genetic basis for clinical response to CTLA-4 blockade in melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Mutated tumor alleles are expressed according to their DNA frequency

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Confidence-based somatic mutation evaluation and prioritization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Exploiting the mutanome for tumor vaccination.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

A vaccine targeting mutant IDH1 induces antitumour immunity

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Adaptive immunity maintains occult cancer in an equilibrium state

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4838069

Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals

20 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNATURE14426

The regulatory landscape for actively personalized cancer immunotherapies

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNATURE14426

21 January 2018

Identifiers

DOI

10.1038/NATURE14426

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25901682%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

PubMed publication ID

25901682

1 reference